Kolon Corporation (002020) investor relations material

Executive summary

• Consolidated revenue for H1 2026 was KRW 3,225.5 billion, up 10.7% year-over-year, with operating profit of KRW 198.6 billion, a 142.9% increase, and net profit of KRW 107.1 billion, marking a return to profitability.

• Major business segments include holding, construction, distribution, IT, bio, and manufacturing, with diversified operations across subsidiaries.

• Significant corporate actions included the full acquisition of Kolon Mobility Group and several mergers and divestitures among subsidiaries.

Financial highlights

• H1 2026 revenue: KRW 3,225.5 billion (+10.7% YoY); operating profit: KRW 198.6 billion (+142.9% YoY); net profit: KRW 107.1 billion (turned positive from loss).

• Total assets: KRW 7,923.3 billion; total liabilities: KRW 5,206.0 billion; total equity: KRW 2,717.3 billion.

• Debt-to-equity ratio: 191.6% (down from 207.3% at end-2025).

• Earnings per share (EPS): KRW 2,327 (basic, common stock) for H1 2026.

• Dividends paid: KRW 550 per common share, KRW 600 per preferred share.

Outlook and guidance

• Management expects continued growth in construction and distribution, with a focus on risk management and capital structure improvement.

• Ongoing clinical trials in the bio segment (notably TG-C for osteoarthritis) are expected to drive future value, with topline data from a key US Phase 3 study released post-reporting period.